NeuroOne Medical Technologies Corporation Common Stock (NMTC) is a publicly traded Healthcare sector company. As of July 26, 2026, NMTC trades at $1.91 with a market cap of $16.54M and a P/E ratio of -21.17. NMTC moved +4.86% today. Year to date, NMTC is -58.22%; over the trailing twelve months it is -64.87%. Its 52-week range spans $1.77 to $8.34. Analyst consensus is strong buy with an average price target of $9.67. Rallies surfaces NMTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NeuroOne Awards 10,000 Options at $3.27, Vesting Over Four Years: NeuroOne granted an option award of 10,000 shares at $3.27 per share under Nasdaq Rule 5635(c)(4) to a new executive, effective June 24, 2026. The ten-year option vests over four years, with 25% vesting on June 24, 2027 and the remainder in quarterly installments, subject to acceleration or forfeiture.
| Metric | Value |
|---|---|
| Price | $1.91 |
| Market Cap | $16.54M |
| P/E Ratio | -21.17 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.34 |
| 52-Week Low | $1.77 |
| Volume | 39.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $9.10M |
| Net Income | $-3.61M |
| Gross Margin | 56.51% |
3 analysts cover NMTC: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.67.